MLTX - MoonLake Immunotherapeutics
18.02
-0.120 -0.666%
Share volume: 760,802
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$18.14
-0.12
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-07-2024 | 11-07-2024 | 02-26-2025 | 05-12-2025 | 11-05-2025 | 02-25-2026 | |
| Cash flow financing | 50.978 M | 0.000 | 183.097 K | 150.706 K | 73.122 M | 480.000 K | 72.395 M | |
| Other financing cash flows | -1.562 M | 0.000 | 183.097 K | 150.706 K | 100.000 K | -100.000 K | 580.000 K | |
| Cash flow | 7.225 M | 0.000 | 33.191 M | -195.654 M | 91.228 M | 44.340 M | -16.310 M | |
| Net income | -13.976 M | -24.759 M | -36.114 M | -46.396 M | -40.559 M | -70.694 M | -63.017 M | |
| Depreciation | 22.813 K | 28.112 K | 32.515 K | 1.301 M | 378.000 K | 745.000 K | 751.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -28.804 M | -87.743 M | 58.282 M | -147.331 M | 56.246 M | 88.403 M | -29.911 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 211.765 K | 0.000 | 132.188 K | 175.567 K | 35.000 K | 0.000 | 0.000 | |
| Cash Change | 7.272 M | -115.650 M | 32.865 M | -195.230 M | 91.140 M | 44.055 M | -16.219 M |